Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression

References

• Steinberg D, Witztum J. Lipoproteins, lipoprotein oxidation and atherogenesis. In: Chien K, editor. Molecular basis of cardiovascular disease. Philadelphia: W.B. Saunders Co.; 1999. p 458–475.
   Google Scholar
• Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell 2001;104:503–516.
   PubMed Web of Science ®Google Scholar
• Witztum JL, Berliner JA. Oxidized phospholipids and isopros-tanes in atherosclerosis. Curr Opin Lipidol 1998;9:441–448.
   PubMed Web of Science ®Google Scholar
• Pentikainen MO, Oorni K, Ala-Korpela M, Kovanen PT. Modified LDL-trigger of atherosclerosis and inflammation in the arterial intima. J Intern Med 2000;247:359–370.
   Google Scholar
• Frostegard J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J. Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb 1992;12:461–467.
   PubMed Web of Science ®Google Scholar
• Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995;92:3893–3897.
   Google Scholar
• Palinski W, Yla-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 1990;10:325–335.
   PubMedGoogle Scholar
• Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, et al. LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers. Arterioscler Thromb 1994;14:1892–1899.
   PubMed Web of Science ®Google Scholar
• Hulthe J, Wiklund O, Hurt-Camejo E, Bondjers G. Antibodies to oxidized LDL in relation to carotid atherosclerosis, cell adhesion molecules, and phospholipase A(2). Arterioscler Thromb Vasc Biol 2001;21: 269–274.
   Google Scholar
• Chang MK, Bergmark C, Laurila A, Horkko S, Han KFI, Friedman P, et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci USA 1999;96:6353–6358.
   PubMed Web of Science ®Google Scholar
• Shaw PX, Horkko S, Chang MK, Curtiss LK, Palinski W, Silverman GJ, et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity [see comments]. J Chin Investig 2000105:1731-1740.
   PubMed Web of Science ®Google Scholar
• Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, et al. Innate and acquired immunity in athero-genesis. Nat Med 2002;8:1218–1226.
   PubMed Web of Science ®Google Scholar
• Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis [see comments]. Lancet 1992;339(8798):883–887.
   PubMed Web of Science ®Google Scholar
• Virella G, Virella I, Leman RB, Pryor MB, Lopes-Virella MF. Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int J Clin Lab Res 1993;23:95–101.
   Google Scholar
• Puurunen M, Manttari M, Manninen V, Tenkanen L, Alfthan G, Ehnholm C, et al. Antibody against oxidized low-density lipoprotein predicting myocardial infarction [published erra-tum appears in Arch Intern Med Apr 24;155(8) (1995) 817]. Arch Intern Med 1994;154(22):2605–2609.
   PubMedGoogle Scholar
• Bergmark C, Wu R, de Faire U, Lefvert AK, Swedenborg J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol 1995;15:441–445.
   Google Scholar
• Palinski W, Tangirala RK, Miller E, Young SG, Witztum JL. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol 1995;15:1569–1576.
   Google Scholar
• Palinski W, Miller E, Witztum JL. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA 1995;92:821–825.
   Google Scholar
• Ameli S, Hultgardh-Nilsson A, Regnstrom J, Calara F, Yano J, Cercek B, et al. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholestemlemic rabbits. Arterioscler Thromb Vasc Biol 1996;16:1074–1079.
   PubMed Web of Science ®Google Scholar
• Freigang S, Horkko S, Miller E, Witztum JL, Palinski W. Immunization of LDL receptor-deficient mice with homo-logous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol 1998;18:1972–1982.
   Google Scholar
• George J, Afek A, Gilburd B, Levkovitz H, Shaish A, Goldberg I, et al. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipo-protein suppresses early atherogenesis. Atherosclerosis 1998;138:147–152.
   PubMed Web of Science ®Google Scholar
• Zhou X, Caligiuri G, Hamsten A, Lefvert AK, Hansson GK. LDL immunization induces T-cell-dependent antibody for-mation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:108–114.
   Google Scholar
• Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Chin Investig 2002;109:745–753.
   PubMed Web of Science ®Google Scholar
• Zhou X, Paulsson G, Stemme S, Hansson GK. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Investig 1998101:1717-1725.
   PubMed Web of Science ®Google Scholar
• Fredrikson GN, Hedblad B, Berglund G, Alm R, Ares M, Cercek B, et al. Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease. Arterioscler Thromb Vasc Biol 2003;23:872–878.
   PubMed Web of Science ®Google Scholar
• Fredrikson GN, Soderberg I, Lindholm M, Dimayuga P, Chyu K-Y, Shah PK, et al. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler Thromb Vasc Biol 2003;23: 879–884.
   Google Scholar
• Barth Jr., RJ, Bock SN, Mule JJ, Rosenberg SA. Unique murine tumor-associated antigens identified by tumor in-filtrating lymphocytes. J Immunol 1990;144:1531–1537.
   Google Scholar
• Cribbs DH, Ghochikyan A, Vasilevko V, Tran M, Petrushina I, Sadzikava N, et al. Adjuvant-dependent modulation of Thl and Th2 responses to immunization with beta-amyloid. Int Immunol 2003;15:505–514.
   PubMed Web of Science ®Google Scholar